These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 813933

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S, Best JM, Banatvala JE, Marshall WC, Dudgeon JA.
    Br Med J (Clin Res Ed); 1982 Jul 24; 285(6337):253-5. PubMed ID: 6807437
    [Abstract] [Full Text] [Related]

  • 23. Rubella antibody titer. The significance of low-titered rubella antibodies.
    Harris RE, Jordon PA, Monif GR.
    Obstet Gynecol; 1978 Aug 24; 52(2):243-5. PubMed ID: 683666
    [Abstract] [Full Text] [Related]

  • 24. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A, Mihail A, Samuel I, Teodosiu O, Isaia G, Ganea E, Motaş C.
    Virologie; 1979 Aug 24; 30(2):109-15. PubMed ID: 111408
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. New Japanese rubella vaccine: comparative trials.
    Best JM, Banatvala JE, Bowen JM.
    Br Med J; 1974 Jul 27; 3(5925):221-4. PubMed ID: 4602899
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
    Hedman K, Hietala J, Tiilikainen A, Hartikainen-Sorri AL, Räihä K, Suni J, Väänänen P, Pietiläinen M.
    J Med Virol; 1989 Apr 27; 27(4):293-8. PubMed ID: 2656909
    [Abstract] [Full Text] [Related]

  • 33. HLA antigens and responses to rubella vaccination.
    Harcourt GC, Best JM, Banatvala JE, Kennedy LA.
    J Hyg (Lond); 1979 Dec 27; 83(3):405-12. PubMed ID: 512353
    [Abstract] [Full Text] [Related]

  • 34. Response to experimental challenge in persons immunized with different rubella vaccines.
    Fogel A, Gerichter CB, Barnea B, Handsher R, Heeger E.
    J Pediatr; 1978 Jan 27; 92(1):26-9. PubMed ID: 619075
    [Abstract] [Full Text] [Related]

  • 35. [Current state of the world's experiences with vaccination against rubella].
    Nassi L, Vecchi C.
    Ann Sclavo; 1975 Jan 27; 17(1):17-33. PubMed ID: 1230035
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A, Horstmann DM, Andiman WA, Randolph MF.
    J Infect Dis; 1978 Dec 27; 138(6):877-83. PubMed ID: 105058
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.